Target intelligence / Profile preview

p53 upregulated modulator of apoptosis (PUMA)

Target
PUMA
Molecular classification
Bcl-2 family, BH3-only proteins
01

Overview

PUMA (p53 upregulated modulator of apoptosis), also known as Bcl-2-binding component 3 (BBC3), is a pro-apoptotic protein and a member of the Bcl-2 family, specifically classified within the BH3-only subgroup. It plays a critical role in regulating apoptosis in response to various cellular stresses. PUMA serves as a proximal signaling molecule that transduces apoptotic signals—primarily from genotoxic stress or cytokine/growth factor withdrawal—to mitochondria. Its ablation leads to resistance against various apoptotic stimuli and contributes to cancer development or therapeutic resistance. A unique feature of PUMA’s mechanism involves “double-bolt locking” anti-apoptotic proteins through both its BH3 domain and CTS—a property conferring resistance against certain small-molecule inhibitors (“BH3 mimetics”).

Other names
Bcl-2-binding component 3BBC3
02

Mechanism of action

Antagonizes antiapoptotic Bcl-2 family proteins, releasing Bax/Bak to induce apoptosis.

03

Biological functions

ApoptosisCell death
04

Disease associations

CancerDrug resistance
05

Safety considerations

Forced expression induces rapid cell death.
06

Interacting drugs

BH3 mimetics

Beyond the preview

Go deeper on p53 upregulated modulator of apoptosis (PUMA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p53 upregulated modulator of apoptosis (PUMA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call